Director of the Cambridge Stem Cell Institute.
Passionate about Blood Stem Cells | Single Cells | Developmental Biology | Healthy Ageing | Leukaemogenesis | Positive Research Culture
More information 👇
www.molgen.mpg.de/embryo2026
Supported by the Weizmann Institute of Science
Applications are now open for the 2026-2027 MPhil - find more details on our website!
They developed a treatment to tackle a common childhood blood cancer, hoping to offer safer & more effective care.
Read more: www.cam.ac.uk/stories/B-AL...
They developed a treatment to tackle a common childhood blood cancer, hoping to offer safer & more effective care.
Read more: www.cam.ac.uk/stories/B-AL...
bsdb.org/2025/03/24/2...
Postdoctoral position – Stem cells, Cancer, and Aging
We study cell fate decision and lineage specification in hematopoietic stem and multipotent progenitor populations to modulate lineage output for therapeutic purpose in diseases and aging contexts.
Postdoctoral position – Stem cells, Cancer, and Aging
We study cell fate decision and lineage specification in hematopoietic stem and multipotent progenitor populations to modulate lineage output for therapeutic purpose in diseases and aging contexts.
We had our first journal club - yes, don’t laugh. It was exciting. Everyone (undergrads to postdoc) presented a section and discussed. Starting is hard but moments like this make all the difference!
We had our first journal club - yes, don’t laugh. It was exciting. Everyone (undergrads to postdoc) presented a section and discussed. Starting is hard but moments like this make all the difference!
www.sciencedirect.com/science/arti...
With the groups of Kamil Kranc and Donal O’Carroll, we have generated a new hematopoiesis model fit for the single cell genomics era.
www.sciencedirect.com/science/arti...
With the groups of Kamil Kranc and Donal O’Carroll, we have generated a new hematopoiesis model fit for the single cell genomics era.